Regeneron Pharmaceuticals (REGN.VI) Q4 2020 Earnings

5NovConfirmed
Q1 2020
Q2 2020
Q3 2020
Q4 2020
4.83
5.57
6.32
7.07

Details

Expected EPS
6.191256
Actual EPS
7.070887999999999
Surprise EPS
0.88
Surprise Percent
+14.21%

Description

Regeneron Pharmaceuticals (REGN.VI) has reported earnings of 7.070887999999999 per share for Q4 2020.

0 Comments

Share your thoughts